ZIPP
The aim is to develop personalized treatments for people with mental illnesses as quickly as possible on the basis of the scientific principles researched at the ZIPP.
The CIMH’s mission statement is “cutting edge research and medicine dedicated to humans suffering from mental disorders and thus for the benefit of society”. The focus of 21st century medicine is the individual. The long-term goal of the Center for Innovative Psychiatry and Psychotherapy Research (ZIPP) is to develop scientific foundations of tailored, individual treatment for psychiatric patients. The ZIPP opened in 2019 after the remodeling and redesign of two floors in CIMH’s therapy building and received funding of approximately 37 million Euro from the state of Baden-Württemberg and the German Federal Ministry of Education and Research.
Innovative, personalized mechanisms
The overall goal of ZIPP is to discover and establish innovative, personalized psychotherapeutic and pharmacotherapeutic mechanisms of action for mental disorders through a novel integrated approach that combines experimental medical and mechanistic neuroscience research.
Four research modules are integrated into a coherent spatial and functional concept, integrated with CIMH’s clinics in the ZIPP:
Unique combination of tools
In recent years, developments in brain imaging combined with the elucidation of biological variance through genetic and genomic approaches have reached a critical level of development. These tools are readily available in the ZIPP.
Here CIMH-Researchers are equipped with a unique combination of tools to achieve the implementation of this highly topical possibility of a fundamentally new translational university-based human research approach in psychiatry.
These tools have been implemented spatially in an environment where psychiatric, psychotherapeutic, and intensive care expertise are directly interwoven and short-term access to neuroscience equipment is available. Pharmacological and psychotherapeutic inventions have different, sometimes rapid onset and time-varying effects on brain function and neuronal plasticity. This makes short distances between intervention units and the imaging and biomarker function areas necessary. Further, psychiatric patients are often particularly vulnerable and dependent on competent treatment teams and the biological complexity and rapid fluctuation of mental disorders requires timely, equipment-intensive characterization.
In the ZIPP, the CIMH scientists are opening up a new research and therapy environment, because new psycho- and pharmaco-therapeutic approaches can be tested efficiently and safely thanks to the spatial proximity and the creation of corresponding new technical equipment.
Significantly improve the treatment
We believe that ZIPP research will change the way we treat patients and help them manage their condition. In the future, we will go beyond the classic diagnoses to reach a better understanding of the causes of mental illness. Thanks to the state of art technologies at ZIPP, we will be able to provide therapeutic support to the affected whenever and wherever it is needed.
Head Neuroimaging and Core Facility ZIPP
Phone: +49 621 1703-2971, e-mail
Secretariat
Astrid Wolf
Phone: +49 621 1703- 2972
We will gladly send you our user regulations on request.
Zentralinstitut für Seelische Gesundheit (ZI) - https://www.zi-mannheim.de